55
Growth Score in past quarter
pts
Heat Score 55 in past quarter
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
721587
CatenaBio develops protein conjugation technologies for personalized therapeutics using its CysTyr™ technology.
- Marco Lobba: Co-Founder & CEO
About the Company
CatenaBio pioneers protein conjugation technologies for novel therapeutic development. The company focuses on creating innovative, personalized therapeutics using its proprietary CysTyr™ technology. This technology allows precise connection to any site on a protein, facilitating the development of multi-payload conjugates. CatenaBio's
advancements have potential applications in biological therapeutics, autoimmune disorders, and vaccine development.